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1 Figure S1: Plasmid map of pCU1 
 
 
Figure S1: Plasmid map of pCU1. aac(3)IV: apramycin resistance gene; int: PhiC31 
integrase gene; llpCI-CIII: polyketide cyclase genes; llpF: ketosynthase  gene; llpE: 
ketosynthase  gene; llpD: ACP gene; llpB’: Fragment of llpB gene coding for an 
hypothetical protein with unknown function; ermEp*: ermE* promoter; RP4ori: RP4 
origin of transfer; attP: PhiC31 attachment site. 
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2 Numbering of pentangular PKS II products 
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3 Physicochemical properties with NMR data of 
lysoquinone-TH1 (7)  
 
Lysoquinone-TH1 (7) was isolated as a red solid with following physical 
characteristics: 
Mr = 462.10 g·mol
-1 (C25H18O9); ESI-MS (negative mode): m/z = 461.1 [M-H]
-. 
(positive mode): m/z = 463.2 [M+H]+; HR-ESI-MS (calculated): m/z = 461.087806 [M-
H]-. (measured): m/z = 461.087756 [M-H]-. (relative mass deviation = 0.11 ppm); IR 
(KBr): ῡ = 3418, 2955, 2921, 2851, 1731, 1714, 1617, 1455, 1375, 1358, 1272, 1172, 
1117, 1073, 799 cm-1; UV (MeOH): λmax (ε) = 515 (1940), 397 (1512), 276 (6231), 
204 (22475) nm. (MeOH/HCl): λmax (ε) = 477 (2532), 284, (5853), 204 (22261) nm. 
(MeOH/NaOH): λmax (ε) = 592 (789), 525 (1628), 395 (1447), 329 (3979), 282 (4127), 
248 (6560), 210 (11986), 207 (12479), 203 (4423) nm. 1H-NMR (600 MHz, DMSO-
d6): δ = 2.18 (s, 3H, 17-H3), 2.67 (d, J = 15.9 Hz, 1H, 2-Ha), 2.70 (s, 2H, 15-H), 
2.91 (d, J = 15.9 Hz, 1H, 2-Hb), 3.01 (d, J = 15.9 Hz, 1H, 4-Ha), 3.25 (d, J = 15.9 Hz, 
1H, 4-Hb), 6.55 (d, 
3J = 2.6 Hz, 1H, 10-H), 6.66 (s, 1H, 5-H), 7.09 (d, 1H, 3J = 2.6 Hz, 
12-H), 9.48 (s, 1H, 14-H) ppm. 13C-NMR (150.6 MHz, DMSO-d6): δ = 32.4 (C-17), 
42.8 (C-4), 52.2 (C-2), 53.3 (C-15), 71.0 (C-3), 107.3 (C-6a), 108.0 (C-12), 108.7 (C-
10), 110.3 (C-8a), 114.4 (C-5), 116.2 (C-7a), 117.7 (C-14b), 118.3 (C-14), 131.4 (C-
13a), 135.6 (C-12a), 136.9 (C-14a), 150.6 (C-4a), 164.3 (C-7, C-9), 164.5 (C-6, C-
11), 182.2 (C-13), 186.6 (C-8), 196.2 (C-1), 207.8 (C-16) ppm. 
No CD-effect or angle of rotation was assessible. 
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4 Figure S2: HPLC and LC-MS of lysoquinone-TH1 (7) and 













Figure S2: A: LC-MS chromatogram of a pre-purified fraction of colored pigments. 
7 Rt = 13.7 minutes; m/z = 461.1 [M-H]
- (red arrow). 8  Rt = 16.5 minutes; m/z = 487.1 
[M-H]- (violet arrow). B: HPLC-UV-DAD (diode array detector) chromatogram of the 
extract with lysoquinone-TH1 (7, red arrow) measured with an acid additive (at 
wavelength of 200 nm). C: Extracted UV spectrum of red pigment 7. D: UV-DAD 
chromatogram of wavelengths of 190–650 nm shows lysoquinone-TH1 (7, red 
arrow). E: HPLC-UV-DAD chromatogram of the extract with lysoquinone-TH2 (8, 
violet arrow), measured with an acid additive (at a wavelength of 200 nm). F: 
Extracted UV spectrum of violet pigment 8. G: UV-DAD chromatogram of 
wavelengths of 190–650 nm shows the violet pigment 8 (violet arrow). 
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5 Figure S3: NMR spectra of lysoquinone-TH1 (7) 
A 
 
B      C 
 





Figure S3: NMR spectra (600 resp. 157.6 MHz, DMSO-d6) of lysoquinone-TH1 (7).  
A: 1H-NMR spectrum of 7 (DMSO-d6, 600 MHz). B: Expansions of the 1H-NMR 
spectrum of 7 in a range of δH = 6.4–7.3 ppm. C: Expansions of the 
1H-NMR of 7 in a 
range of δH = 2.1-3.3 ppm. D: 
13C-NMR of 7. E: Detailed 1H- and 13C NMR 
assignments ( in ppm). 
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Figure S4: NMR spectra (600 resp. 157.6 MHz, DMSO-d6) of 13C-enriched 
lysoquinone-TH1 (7) from doubly labeled [1,2-13C2]acetate feeding experiments.  
A: 1H-NMR (DMSO-d6; 600 MHz) of lysoquinone-TH1 (7) with 13C-enrichment. B: 
Expansions of the 1H-NMR of enriched 7 (δH = 6.1–7.5 ppm). C: Expansions of the 
1H-NMR of enriched 7 (δH = 2.60–3.60 ppm). D: 
13C-NMR (DMSO-d6; 150 MHz) of 
lysoquinone-TH1 (7) with 13C-enrichment. E: Expansions of enriched 7 (δC = 195–
210 ppm). F: Expansions of 7 (δC = 179–189 ppm). G: Expansions of 7 (δC = 157-167 
ppm). H: Expansions of 7 (δC = 145–155 ppm). I: Expansions of 7 (δC = 130–
140 ppm). K: Expansions of 7 (δC = 106–121 ppm). L: Expansions of 7 (δC = 65-75 
ppm). M: Expansions of 7 (δC = 47–57 ppm). N: Expansions of 7 (δC = 41–46 ppm). 
O: Expansions of 7(δC = 30–35 ppm). 
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7 Figure S5: 2D-NMR data of lysoquinone-TH1 (7) 
 
Structure of lysoquinone-TH1 (7)  





Figure S5: HMBC cross correlations of lysoquinone-TH1 (7) within the chemical shift 
of carbon atoms (red) and hydrogen atoms (different colors for enhanced overview). 
Depicted two-dimensional NMR-spectra with selected cross correlations: COSY-, 
HSQC-HMBC-experiment (next pages). 
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Figure S5A: COSY / HSQC correlations 
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Figure S5B: HMBC correlations 
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8 Figure S6: 13C enrichment of 7: Structure, Table S1  
 
 
Figure S6: A: Suggested PKS chain of the tridecaketide as precursor of 
lysoquinone-TH1 (7). 
B: Structural formula of 7 depicting intact acetate units from [1,2-13C2]-labeled 
acetate on the basis of this study and previous results (see references) C: 
Lysoquinone-TH1 (7) with assigned 13C-13C-coupling constants and specific 
incorporation (calculation, see below). 
 
[1,2-13C2]-labeled acetate was purchased with 99% enrichment (Cambridge Isotope 
laboratories, Inc.). 13C enrichment in the isolated lysoquinone-TH1 (7) was calculated 
as described by Scott et al., J. Am. Chem. Soc. 1974, 96, 8069-8080: 
Integrals of coupling signals of carbon atoms were calculated as the sum of the 
integral of the full multiplets. Assigned to the natural enrichment, the central signal of 
the methyl 13C carbon atom C-17 of lysoquinone-TH1 (7) was used as the non-13C-
enriched internal reference signal. 
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Integrals for singlet signals of respective carbon atoms were calculated using the 
integral of the central line (ICL) of the multiplets and the usual singlet signals. All 
carbon atoms turned out to be enriched (Table S1, and see Fig S6 C). 
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Table S1: Level of enrichment and specific incorporation of lysoquinone-TH1 (7), 




















C-1 196.2 125680.67 39478.23 0.03 2.8 C-2 
C-2 52.2 272409.62 67517.08 0.04 3.9 C-1, C-3 
C-3 71.0 239294.07 39925.74 0.06 6.3 C-2, C-4 
C-4 42.8 252561.56 56466.40 0.04 4.4 C-3 
C-4a 150.6 119859.13 35293.11 0.03 3.1 C-5 
C-5 114.4 164560.28 38021.24 0.04 4.3 C-4a 
C-6 164.5 230040.07 36491.45 0.07 6.7 C-6a 
C-6a 107.3 155109.45 26769.51 0.06 6.1 C-62 
C-7 164.3 148500.54 26779.16 0.06 5.8 C-7a 
C-7a 116.2 92927.53 --- --- --- C-7 
C-8 186.6 106031.71 --- --- --- C-8a 
C-8a 110.3 121111.92 28617.71 0.04 4.1 C-8 
C-9 164.3 148500.54 26779.16 0.06 5.8 C-10 
C-10 108.7 258956.65 38026.93 0.07 7.3 C-9 
C-11 164.5 230040.07 36491.45 0.07 6.7 C-12 
C-12 108.0 218910.11 38897.04 0.06 5.9 C-11 
C-12a 135.6 128030.79 32670.37 0.04 3.8 C-13 
C-13 182.2 113731.76 28538.17 0.04 3.8 C-12a 
C-13a 131.4 116592.22 32613.67 0.03 3.3 C-14 
C-14 118.3 126176.64 33066.76 0.04 3.6 C-13a 
C-14a 136.9 121559.05 29922.87 0.04 3.9 C-14b 
C-14b 117.7 156522.22 62356.91 0.02 2.0 C-14a 
C-15 53.3 281943.39 58169.04 0.05 4.9 C-16 
C-16 207.8 162065.11 36747.45 0.04 4.4 C-15 
C-17 32.4 328644.60 72761.44 0.00 0.0 --- 
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Figure S7: Inhibition assay of the enzyme PDE-4B2 by lysoquinone-TH1 (7). The 
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